Discover central players in the molecular mechanisms that drive the cell, tissue functions and phenotypes associated with your disease of interest. Assess their suitability as therapeutic targets on multiple criteria. Available as platform subscription or consulting service.
TARGET DISCOVERY EXAMPLE
Discover key players in the molecular interactions driving disease pathology
Leverage our millions of gene annotations and combine these with your personal data. Discover and evaluate how molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology. Identify potential novel target candidates driving these pathologies.
Efficacious, Druggable and Safe targets
From the list of potential candidates, evaluate most promising therapeutic targets by ranking, filtering and scoring simultaneously on multiple key aspects of efficacy, druggability & safety.
Latest Target Discovery News
Literature monitoring by Euretos detects over 550 ‘first ever’ gene-cancer mentions in Pubmed each monthFriday 14 December 2018
In a recent study published in Cellular SIgnalling, researchers identified MAP2K6 (also known as MKK6) as a novel potential target for Esophageal adenocarcinoma (EAC), an aggressive form of cancer with a 5-year survival rate of less than 15%. As pa ...
Researchers find novel gene driving suppression of the immune response by tumorsTuesday 10 October 2017
One of the key areas of cancer research today is understanding how tumors suppress the immune response. In a recent study published in Cell Reports researchers have now identified one of the central players driving this mechanism: the DNMT3A gene. ...